Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established, prestigious institution that has performed preclinical testing services for several vaccines and antivirals.

21 Sep 2009

Obama lobbies the public, fellow Dems and one GOP senator

In his Sunday talk show appearance, President Obama conceded that he has not been "breaking through" on the health care debate, the Chicago Tribune reports. "I think there have been times where I have said, 'I've got to step up my game in terms of talking to the American people about issues like health care,'" he said, after reporters asked whether he'd lost control of the debate.

21 Sep 2009

Chronic viruses found living in prostate tumors

According to Dr. Ila R. Singh, an associate professor of pathology at the University of Utah, "for the first time we have analyzed prostate cancer and normal prostate tissue and found cancers are much more likely to have [the XMRV virus] ... It was also more likely to be present in more aggressive tumors," Singh said. "We found it in 20 percent of the least aggressive tumors and over 45 percent of the most aggressive tumors."

21 Sep 2009

U.S. Department of Health & Human Services requests BioCryst for proposal for peramivir supply

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).

21 Sep 2009

HHS awards $77.2 million contract to BioCryst to complete Phase 3 development of peramivir

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

Flu Preparedness Program offering latest information on the H1N1 virus

TeleVox Software, Inc., a leading provider of communication solutions for the healthcare industry, today launched its Flu Preparedness Program (www.televox.com/fluprogram), designed to enable health care providers to give their patients the latest information about fighting the Flu and the H1N1 virus, commonly referred to as the swine flu. Doctors can easily communicate with their patients through a variety of methods such as voice, email, postcards and text messages.

21 Sep 2009

No communication to workers from employers about policies in the workplace pertaining to H1N1: Study

Most workers have not had any direction from their employers about the upcoming flu season, according to a national survey released today by Mansfield Communications Inc.

21 Sep 2009

SmarterTravel releases precautionary checklist for travelers regarding swine flu

SmarterTravel(R), a comprehensive travel advice resource for the budget-conscious traveler, today released a checklist of strategies for staying safe while traveling during this highly anticipated flu season.

21 Sep 2009

Vaccine Global Congress organized by Elsevier's Vaccine journal

Elsevier, a leading publisher of scientific, technical and medical information products and services, announced today, that its journal Vaccine, the most comprehensive and pre-eminent journal for those interested in vaccines and vaccination, will organize the 3rd Vaccine Global Congress from 4-6 October, 2009, in Singapore.

21 Sep 2009

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).

21 Sep 2009

"We are going to make sure healthcare is affordable and accessible for everybody": SEIU

"This is a moment of profound change for this country -- from kitchen tables to town halls to the floor of the Senate, this nation is engaged in a vigorous and heated debate about how we rebuild our economy, solve our national healthcare crisis and restore the American Dream.

21 Sep 2009

ICTs play a major role in the health care sector

Today the GridTalk project launches its 8th GridBriefing at the Enabling Grids for E-sciencE (EGEE) conference in Barcelona. The report covers how information and communication technologies (ICTs), particularly computing grids, are used in the health and biomedical sectors of European research. EGEE has supported this research community since the project's birth and it is the second largest user group after physics research.

21 Sep 2009

Praxair China installs NCOOL system at Shanghai Pharmaceutical

Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair’s patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.

21 Sep 2009

Influenza vaccination low among healthcare workers

Less than one third of healthcare workers have themselves vaccinated against classic influenza. This reluctance is astounding, firstly because vaccination against influenza viruses is considered safe and effective and secondly because it has been proved to prevent nosocomial transmission of disease to patients-provided at least 50% of employees have been vaccinated.

21 Sep 2009